StockData
ADARx Pharmaceuticals, Inc. logo

ADARx Pharmaceuticals, Inc. (ADRX) stock

ADRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Last filing: 10-Q on Nov 12, 2026
$13.82−0.18 (-1.29%)

Close on Nov 17, 2026Market cap $1.48BP/E –Yield –

ADARx Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

No enterprise value figures for ADARx Pharmaceuticals

ADARx Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More ADARx Pharmaceuticals figures

See a number that looks wrong?